Amarin Corp Plc (AMRN)

[north40000]

Must be 3-4 a.m in Hungary.

BB, in your searches in past or recently, have you seen any literature where Vascepa (or other EPAs ) is/are combined with another molecule different from a statin that achieves a CVD risk reduction comparable or better than the results shown in Reduce-It trial.

Note KM’s comments near the end of his Wainwright interview today…”there are many other molecules where it makes sense to put them with Vascepa….our intent is to have a fixed dose combination portfolio[besides one employing a statin]”.